Octreotide Acetate
Product Images NDC 64679-635
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 64679-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wockhardt Usa Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (Octreotideaceinj Figure 02)
This is a description of a medication. It contains Octreotide Acetate in a 1 mL single-dose vial with a strength of 50 mg/1 mL (0.05mg/mL) and NDC 6467963601. The medication is distributed by Wockhardt USA LLC and should be protected from light. It is indicated for subcutaneous use. The lot number and expiration date are also provided.*
Carton (Octreotideaceinj Figure 03)
Octreotide Acetate is a medication used for the treatment of acromegaly, carcinoid syndrome, and other similar conditions. It is available in a solution form of 50mcg/mL, contained in 1mL single-dose vials. The medication should be stored at a refrigerated temperature range of 2°C to 8°C until use and must be kept away from light. The packaging insert should be reviewed for more information about the medicine's dosage and recommended administration technique. The product is distributed in the United States by Wockhardt USA LLC.*
Label (Octreotideaceinj Figure 04)
Carton (Octreotideaceinj Figure 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.